Description

---

1. Acute Myeloid Leukemia (AML), by Elihu Estey
2. The Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Risk Stratification and Strategies, by Andrei R. Shustov
3. Chronic Lymphocytic Leukemia (CLL), by Jonathan A. Gutman, Kelly M. Smith, and John M. Pagel
4. Chronic Myelogenous Leukemia (CML), by Vivian Oehler and Jerry Radich
5. Myelodysplastic Syndromes (MDS), by Bart Lee Scott
6. Myeloablative transplant (HCT), by Gunnar Bjarni Ragnarsson and Paul J. Martin
7. Reduced-intensity and Non-Myeloablative Conditioning Followed by Hematopoietic Cell Transplantation, by Aravind Ramakrishnan and Brenda M. Sandmaier
8. Alternative Donor Hematopoietic Stem Cell Transplantation - A Role for Umbilical Cord Blood Transplantation for Hematologic Malignancies, by Laura F. Newell, Jonathan A. Gutman, and Colleen Delaney
9. The Detection and Significance of Minimal Residual Disease, by Jerald P. Radich and Brent L. Wood
10. Late Effects after Treatment for Leukemia, by K. Scott Baker and Emily Jo Rajotte
11. Transfusion Support of the Patient with Hematologic Malignancy, by Terry B. Gernsheimer and Meghan Delaney
12. Infections in Leukemia and Hematopoietic Stem Cell Transplantation, by Steven Pergam, Debra Mattson, and Michael Boeckh

About the Author

---

Elihu H. Estey, M.D.Professor of MedicineDivision of HematologyUniversity of Washington School of MedicineMember, Fred Hutchinson Cancer Research Center Attending Physician, Seattle Cancer Care AllianceSeattle, WA USA Frederick R. Appelbaum, MD Professor of MedicineHead, Division of OncologyDirector, Clinical Research Division, Fred Hutchinson Cancer Research CenterExecutive Director, Seattle Cancer Care AllianceUniversity of Washington School of MedicineSeattle, WA USA